Has your child been confronted by doctors, teachers, counselors, or therapists with gender questioning? Did this happen in your absence? Were you made aware of the risks of treatment for gender dysphoria?
This month the Federal Trade Commission (FTC) launched a public inquiry to collect data from consumers about their exposure to misinformation about the benefits of "affirming care” for minors, and to assess any harms caused by deceptive trade practices.
The FTC’s request for information builds off a July workshop where doctors, medical ethicists, whistleblowers, detransitioners, and parents of detransitioners spoke about their experiences with what is known as affirming care, and how medical practitioners may be deceiving patients.
In particular, the FTC is interested in potential violations of Sections 5 and 12 of the FTC Act, which would include instances where doctors or organizations failed to disclose material risks, or made unsubstantiated claims about the effectiveness of “gender-affirming care.”
If your family has been confronted with this problem, you have the opportunity to make your concerns know. The FTC has set up a comment forum for the next 60 days where you can submit comments.
Alerting the FTC about any deceptive practices can be a beginning to restored protections for families. For more information see the research of the Manhattan Institute on this important issue.
You never want to leave your child alone with a health care professional. Even if your absence is requested, you should not leave, and you should ask for a list of whatever questions they intended to ask your child. Reporting this then to the proper oversight authorities is critical.
Parents are the best protectors of their children regarding gender care.
No comments:
Post a Comment